Evidence map›Paper›PMID 39449610›Full record

Trial reportEpidemiology and psychiatric sciences2024

The effectiveness of Problem Management Plus at 1-year follow-up for Syrian refugees in a high-income setting.

Anne M de Graaff, Pim Cuijpers, Mariam Elsawy, Sam Hunaidy, Barbara Kieft, Noer Gorgis, Jos W R Twisk, Yenovk Zakarian, Theo K Bouman, Miriam J J Lommen and 7 more

Abstract readRandomized Controlled Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Epidemiology and psychiatric sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Anne M de GraaffDepartment of Clinical, Neuro- and Developmental Psychology, WHO Collaborating Center for Research and Dissemination of Psychological Interventions, Amsterdam Public Health Research Institute, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.ORCID https://orcid.org/0000-0001-6686-4432
Pim CuijpersDepartment of Clinical, Neuro- and Developmental Psychology, WHO Collaborating Center for Research and Dissemination of Psychological Interventions, Amsterdam Public Health Research Institute, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.ORCID https://orcid.org/0000-0001-5497-2743
Mariam ElsawyDepartment of Clinical, Neuro- and Developmental Psychology, WHO Collaborating Center for Research and Dissemination of Psychological Interventions, Amsterdam Public Health Research Institute, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
Sam HunaidyDepartment of Clinical, Neuro- and Developmental Psychology, WHO Collaborating Center for Research and Dissemination of Psychological Interventions, Amsterdam Public Health Research Institute, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
Barbara KieftARQ National Psychotrauma Centre, ARQ Centrum '45, Diemen, The Netherlands.
Noer Gorgisi-Psy, Parnassia Groep, Almere, The Netherlands.
Jos W R TwiskDepartment of Epidemiology and Data Science, VU University Medical Centre Amsterdam, Amsterdam, The Netherlands.
Yenovk ZakarianDepartment of Clinical, Neuro- and Developmental Psychology, WHO Collaborating Center for Research and Dissemination of Psychological Interventions, Amsterdam Public Health Research Institute, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
Theo K BoumanClinical Psychology and Experimental Psychopathology, University of Groningen, Groningen, The Netherlands.
Miriam J J LommenClinical Psychology and Experimental Psychopathology, University of Groningen, Groningen, The Netherlands.
Ceren AcarturkDepartment of Psychology, Koc University, Istanbul, Turkiye.ORCID https://orcid.org/0000-0001-7093-1554
Richard BryantSchool of Psychology, University of New South Wales, Sydney, Australia.ORCID https://orcid.org/0000-0002-9607-819X
David McDaidCare Policy and Evaluation Centre, Department of Health Policy, London School of Economics and Political Science, London, UK.
Naser MorinaDepartment of Consultation-Liaison Psychiatry and Psychosomatic Medicine, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
A-La ParkCare Policy and Evaluation Centre, Department of Health Policy, London School of Economics and Political Science, London, UK.
Peter VentevogelPublic Health Section, United Nations High Commissioner for Refugees, Geneva, Switzerland.
Marit SijbrandijDepartment of Clinical, Neuro- and Developmental Psychology, WHO Collaborating Center for Research and Dissemination of Psychological Interventions, Amsterdam Public Health Research Institute, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.ORCID https://orcid.org/0000-0001-5430-9810

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsProblem Management Plus (PM+) has been effective in reducing mental health problems among refugees at three-month follow-up, but there is a lack of research on its long-term effectiveness. This study examined the effectiveness of PM+ in reducing symptoms of common mental disorders at 12-month follow-up among Syrian refugees in the Netherlands.

methodsThis single-blind, parallel, controlled trial randomised 206 adult Syrians who screened positive for psychological distress and impaired functioning to either PM+ in addition to care as usual (PM+/CAU) or CAU alone. Assessments were at baseline, 1 week and 3 months after the intervention and 12 months after baseline. Outcomes were psychological distress (Hopkins Symptom Checklist [HSCL-25]), depression (HSCL-25 subscale), anxiety (HSCL-25 subscale), posttraumatic stress disorder symptoms (PCL-5), functional impairment (WHODAS 2.0) and self-identified problems (PSYCHLOPS).

resultsIn March 2019-December 2022, 103 participants were assigned to PM+/CAU and 103 to CAU of which 169 (82.0%) were retained at 12 months. Intention-to-treat analyses showed greater reductions in psychological distress at 12 months for PM+/CAU compared to CAU (adjusted mean difference -0.17, 95% CI -0.310 to -0.027;

conclusionsPM+ is effective in reducing psychological distress and symptoms of anxiety over a period up to 1 year. Additional support such as booster sessions or additional (trauma-focused) modules may be required to prolong and consolidate benefits gained through PM+ on other mental health and psychosocial outcomes.

Indexed as

AnxietyRefugeesStress Disorders, Post-TraumaticAdultDepressionFemaleFollow-Up StudiesHumansMaleMental DisordersMiddle AgedNetherlandsPsychological DistressSingle-Blind MethodStress, PsychologicalSyriadepressionposttraumatic stress disorderrandomised controlled trialstask sharing

Identifiers

PMID39449610
PMCPMC11588643

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.